Diane Mege

Diane Mege

Auto-generated profile, based on publicly available information

Diane Mege

Department of Digestive Surgery, Aix Marseille Univ, APHM, Timone University Hospital, Marseille, France

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2018 in Cancers
Verified
Journal Article
Open access
PDF file
LPLéa Plantureux
Léa Plantureux
DMDiane Mège
Diane Mège
LCLydie Crescence
Lydie Crescence
FDFrançoise Dignat-George
Françoise Dignat-George
Christophe DuboisChristophe Dubois
Christophe Dubois
LPLaurence Panicot-Dubois
Laurence Panicot-Dubois
Platelets are small anucleate cells that are traditionally described as the major effectors of hemostasis and thrombosis. However, increasing evidence indicates that platelets play several roles in the progression of malignancies and in cancer-associated thrombosis. A notable cross-communication exists between platelets and cancer cells. On one hand, cancer can “educate” platelets, influencing their RNA profiles, the numbers of circulating platelets and their activation states. On the other hand, tumor-educated platelets contain a plethora of active biomolecules, including platelet-specific and circulating ingested biomolecules, that are released upon platelet activation and participate in the progression of malignancy. The numerous mechanisms by which the primary tumor induces the production, activation and aggregation of platelets (also known as tumor cell induced platelet aggregation, or TCIPA) are directly related to the pro-thrombotic state of cancer patients. Moreover, the activation of platelets is critical for tumor growth and successful metastatic outbreak. The development or use of existing drugs targeting the activation of platelets, adhesive proteins responsible for cancer cell-platelet interactions and platelet agonists should be used to reduce cancer-associated thrombosis and tumor progression.

Verified
Journal Article
Open access
PDF file
PHPierre HAEN
Pierre HAEN
DMDiane Mege
Diane Mege
LCLydie Crescence
Lydie Crescence
FDFrançoise Dignat-George
Françoise Dignat-George
Christophe DuboisChristophe Dubois
Christophe Dubois
LPLaurence Panicot-Dubois
Laurence Panicot-Dubois
Venous thromboembolism (VTE) is a common complication for cancer patients. VTE-associated risk varies according to the type of tumor disease. Head and neck cancer is a common cancer worldwide, and most tumors are squamous cell carcinomas due to tobacco and alcohol abuse. The risk of VTE associated with head and neck (H&N) cancer is considered empirically low, but despite the high incidence of H&N cancer, few data are available on this cancer; thus, it is difficult to state the risk of VTE. Our review aims to clarify this situation and tries to assess the real VTE risk associated with H&N cancer. We report that most clinical studies have concluded that there is a very low thrombosis risk associated with H&N cancer. Even with the biases that often exist, this clinical review seems to confirm that the risk of VTE was empirically hypothesized. Furthermore, we highlight that H&N cancer has all the biological features of a cancer associated with a high thrombosis risk, including a strong expression of procoagulant proteins, modified thrombosis/fibrinolysis mechanisms, and secretions of procoagulant microparticles and procoagulant cytokines. Thus, this is a paradoxical situation, and some undiscovered mechanisms that could explain this clinical biological ambivalence might exist.

1 October 2018 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
DMDiane Mege
Diane Mege
GMGilles Manceau
Gilles Manceau
LBLaura Beyer-Berjot
Laura Beyer-Berjot
VBValérie Bridoux
Valérie Bridoux
ZLZaher Lakkis
Zaher Lakkis
KFKévin Fixot
Kévin Fixot

2 August 2017 in Colorectal Disease
Verified
Journal Article
Closed access
PDF file
DMD. Mege
D. Mege
GMG. Meurette
G. Meurette
VVV. Vitton
V. Vitton
ALA.‐M. Leroi
A.‐M. Leroi
VBV. Bridoux
V. Bridoux
CNClub NEMO
Club NEMO

2 April 2019 in International Journal of Colorectal Disease
Verified
Journal Article
Closed access
PDF file
OGOn behalf of the AFC (French Surgical Association) Working Group
On behalf of the AFC (French Surgical Association) Working Group
DMDiane Mege
Diane Mege
GMGilles Manceau
Gilles Manceau
LBLaura Beyer
Laura Beyer
VBValérie Bridoux
Valérie Bridoux
MKMehdi Karoui
Mehdi Karoui

1 September 2019 in Langenbeck's Archives of Surgery
Verified
Journal Article
Closed access
PDF file
OGOn behalf of the AFC (French Surgical Association) Working Group
On behalf of the AFC (French Surgical Association) Working Group
GMGilles Manceau
Gilles Manceau
TVThibault Voron
Thibault Voron
DMDiane Mege
Diane Mege
VBValérie Bridoux
Valérie Bridoux
MKMehdi Karoui
Mehdi Karoui